- Ozoralizumab
-
Ozoralizumab ? Monoclonal antibody Type Whole antibody Source Humanized Target Lama glama Clinical data Pregnancy cat. ? Legal status ? Identifiers CAS number 1167985-17-2 ATC code None Chemical data Formula C1682H2608N472O538S12 Mol. mass 38.43 kDa (what is this?) (verify)
Ozoralizumab is a humanized monoclonal antibody designed for the treatment of inflammatory diseases.
Ozoralizumab was developed by Pfizer Inc.
References
Monoclonal antibodies for the immune system Immune system ("-l(i[m])-") Interleukin ("-k(i[n])-") Human ("-kinu-")Humanized ("-kizu-", "-kinzu-")Inflammatory lesions ("-les-") Mouse ("-leso-")#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.